Back to URGN

ACORN CAPITAL ADVISORS, LLC → URGN

ACORN CAPITAL ADVISORS, LLC URGN Position History

UroGen Pharma Ltd. • Healthcare

Quarters held
4
Latest value
$67M
Q3 2026
Peak value
$67M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$33.9M
Q1 2026$30.1M
Q2 2026$61.6M
Q3 2026$67M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$67M1.65M——
Q2 2026$61.6M1.67M——
Q1 2026$30.1M1.67M——
Q4 2025$33.9M1.45M——

Other funds holding URGN

Other ACORN CAPITAL ADVISORS, LLC positions

CGON

CG ONCOLOGY INC

$80.4M
CGON

CG ONCOLOGY INC

$80.2M
CGON

CG ONCOLOGY INC

$76.6M
CGON

CG ONCOLOGY INC

$47M
TRVI

TREVI THERAPEUTICS INC

$40M
CGC

CANDEL THERAPEUTICS INC

$36.5M
CGC

CANDEL THERAPEUTICS INC

$36M
TRVI

TREVI THERAPEUTICS INC

$30.7M